Search

You searched for "prostatic"

471 results found

Demanding cases or nightmares in uro-oncology? Sep/Oct 2022

5 September 2022 | | Urologic Oncology
Treatment of prostate cancer in renal transplant recipients is challenging due to a lack of knowledge of the natural history of cancer in these patients, the anatomical position of the graft in the iliac fossa and its proximity to the...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | Basic Science Research, Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

PROFILE study seeks to find out why black men develop prostate cancer at twice the rate of other men

1 December 2020 | Urologic Oncology
A first-of-its-kind study in the UK is aiming to solve the mystery of why black men develop prostate cancer at twice the rate of other men. Funded by Prostate Cancer UK in partnership with Movember, the PROFILE study will look...

What’s new in post prostatectomy incontinence?

1 January 2017 | | Functional Urology
With an ageing population, the number of men being diagnosed with prostate cancer each year is steadily rising. With more specific investigations, such as multiparametric magnetic resonance imaging (MpMRI) and transperineal biopsies, the number of cases diagnosed at an earlier...

Importance of PSA variation – an analysis of PLCO trial data

1 January 2016 | | Urologic Oncology
This study looks specifically at the group of patients in the intervention arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial (PLCO), to investigate variations in prostate specific antigen (PSA) level. They have specifically included only patients who...

Rotterdam Prostate Cancer Risk app

1 July 2014 | | Urologic Oncology, Technological Developments
The widespread use of prostate specific antigen (PSA) testing has led to diagnostic difficulties for patients and urologists. The sensitivity and specificity characteristics of PSA are far from optimal. To try and improve the predictive accuracy of PSA measurements, nomograms...

Read all about it Jul/Aug 2016

1 July 2016 | Andrology, Basic Science Research, Endourology and Stones, Functional Urology, Infection, Neurourology, Paediatric Urology, Reconstructive Urology, Technological Developments, Trauma and Emergency Urology, Urologic Oncology, Uroradiology
It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking about! So this section...

The stonecutters of 17th Century London

1 July 2015 | | Endourology and Stones, Technological Developments
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I told you about the prostatic punch. If you...

Prostate Cancer 2024

Prostate Cancer 2024 UK urology has truly been at the forefront of clinical research to change the prostate cancer pathway for the better. We should be rightly proud of what we have achieved over the last 10 years together in...

MOWOOT II Intestinal Transit Management System

1 November 2020 | Research & Development
MOWOOT II is an intermittent colonic exo-peristaltic therapy system for intestinal transit disorders, such as slow transit constipation. MOWOOT II utilises advanced pneumatic technology to treat and prevent chronic constipation without laxatives, enemas...

Focal therapies in prostate cancer

1 November 2018 | | Technological Developments, Urologic Oncology
The standard of care in the management of prostate cancer has, to date, always been to treat the whole gland. This has ranged from surveillance, surgical excision / prostatectomy or external beam radiotherapy / whole gland brachytherapy. With the evolution...

COVID-19 cuts prostate cancer referrals in half

7 October 2020 | COVID-19 - Urology News, Urologic Oncology
Charity warns that 3500 men risk being diagnosed with incurable cancer as referrals drop to lowest in 10 years Urgent referrals for urological cancers have dropped by half in England (49.5%) compared to the same period last year as the...